<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Patient Health Record</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body>
<h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Allergies</a></li><li><a href="#id2">Results</a></li><li><a href="#id3">Reason For Referral</a></li><li><a href="#id4">Medications</a></li><li><a href="#id5">Immunizations</a></li><li><a href="#id6">Social History</a></li><li><a href="#id7">Problems</a></li><li><a href="#id8">Vital Signs</a></li><li><a href="#id9">Procedures</a></li><li><a href="#id10">Encounters</a></li><li><a href="#id11">Medical Equipment</a></li><li><a href="#id12">Assessments</a></li><li><a href="#id13">Plan Of Treatment</a></li><li><a href="#id14">Goals Section</a></li><li><a href="#id15">Health Concerns</a></li><li><a href="#id16">Insurance Providers</a></li><li><a href="#id17">Medical (General) History</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Allergies</a></h3><div><table width="100%" border="1"><thead><tr><th>Allergen (clinical drug ingredient)</th><th>Drug/Non Drug Allergy documented on EMR</th><th>Reaction</th><th>Allergy Type</th><th>Onset Date</th><th>Status</th></tr></thead><tbody><tr><td ID="allergy1">losartan</td><td>Losartan Potassium</td><td ID="reaction1">cough</td><td>Drug Allergy</td><td/><td>Active</td></tr></tbody></table></div><h3><a name="id2" href="#toc">Results</a></h3><div><table width="100%" border="1"><thead><tr><th>Component</th><th>Value</th><th>Reference Range</th><th>Notes</th></tr></thead><tbody><tr><td colspan="4"><span class="content_span">URINALYSIS, COMPLETE W/REFLEX TO CULTURE (3020)</span><br/>Reviewed date:[REDACTED] 12:58:46 PM<br/>Interpretation:<br/>Performing Lab:MI, Quest Diagnostics-Miami
[REDACTED][REDACTED] Julie L Friedman<br/>Notes/Report:<br/>FASTING: UNKNOWN<br/>FASTING: UNKNOWN</td></tr><tr><td ID="result1_attr1">COLOR</td><td>YELLOW</td><td>YELLOW</td><td/></tr><tr><td ID="result1_attr2">APPEARANCE</td><td>CLEAR</td><td>CLEAR</td><td/></tr><tr><td ID="result1_attr3">SPECIFIC GRAVITY</td><td>1.021</td><td>1.001-1.035</td><td/></tr><tr><td ID="result1_attr4">PH</td><td>&lt; OR = 5.0</td><td>5.0-8.0</td><td/></tr><tr><td ID="result1_attr5">GLUCOSE</td><td>NEGATIVE</td><td>NEGATIVE</td><td/></tr><tr><td ID="result1_attr6">BILIRUBIN</td><td>NEGATIVE</td><td>NEGATIVE</td><td/></tr><tr><td ID="result1_attr7">KETONES</td><td>NEGATIVE</td><td>NEGATIVE</td><td/></tr><tr><td ID="result1_attr8">OCCULT BLOOD</td><td>NEGATIVE</td><td>NEGATIVE</td><td/></tr><tr><td ID="result1_attr9">PROTEIN</td><td>TRACE</td><td>NEGATIVE</td><td/></tr><tr><td ID="result1_attr10">NITRITE</td><td>NEGATIVE</td><td>NEGATIVE</td><td/></tr><tr><td ID="result1_attr11">LEUKOCYTE ESTERASE</td><td>NEGATIVE</td><td>NEGATIVE</td><td/></tr><tr><td ID="result1_attr12">WBC</td><td>NONE SEEN</td><td>&lt; OR = 5 /HPF</td><td/></tr><tr><td ID="result1_attr13">RBC</td><td>NONE SEEN</td><td>&lt; OR = 2 /HPF</td><td/></tr><tr><td ID="result1_attr14">SQUAMOUS EPITHELIAL CELLS</td><td>NONE SEEN</td><td>&lt; OR = 5 /HPF</td><td/></tr><tr><td ID="result1_attr15">BACTERIA</td><td>NONE SEEN</td><td>NONE SEEN /HPF</td><td/></tr><tr><td ID="result1_attr16">CALCIUM OXALATE CRYSTALS</td><td>MODERATE</td><td>NONE OR FEW /HPF</td><td/></tr><tr><td ID="result1_attr17">HYALINE CAST</td><td>NONE SEEN</td><td>NONE SEEN /LPF</td><td/></tr><tr><td ID="result1_attr18">NOTE</td><td/><td/><td ID="result1_attr18_notes"><p>RBC, bacteria, casts, and other formed elements.</p><p>This urine was analyzed for the presence of WBC,</p><p>Only those elements seen were reported.</p></td></tr><tr><td ID="result1_attr19">REFLEXIVE URINE CULTURE</td><td/><td/><td ID="result1_attr19_notes">NO CULTURE INDICATED</td></tr><tr><td colspan="4"><span class="content_span">ALBUMIN, RANDOM URINE W/CREATININE (6517)</span><br/>Reviewed date:[REDACTED] 11:08:30 PM<br/>Interpretation:<br/>Performing Lab:MI, Quest Diagnostics-Miami
[REDACTED][REDACTED] Julie L Friedman<br/>Notes/Report:<br/>FASTING:YES<br/>FASTING: YES</td></tr><tr><td ID="result2_attr1">CREATININE, RANDOM URINE</td><td>130</td><td>20-320 mg/dL</td><td/></tr><tr><td ID="result2_attr2">ALBUMIN, URINE</td><td>7.7</td><td>See Note: mg/dL</td><td ID="result2_attr2_notes"><p>Reference Range:</p><p>Not established</p><p>Reference Range</p></td></tr><tr><td ID="result2_attr3">ALBUMIN/CREATININE RATIO, RANDOM URINE</td><td>59</td><td>&lt;30 mg/g creat</td><td ID="result2_attr3_notes"><p>excretion as follows:</p><p>specimens collected within a 3-6 month period be</p><p>Albuminuria Category        Result (mg/g creatinine)</p><p>The ADA recommends that at least two of three</p><p>within a diagnostic category.</p><p>Severely increased           &gt; OR = 300</p><p>abnormal before considering a patient to be</p><p>The ADA defines abnormalities in albumin</p><p>Moderately increased         30-299</p><p>Normal to Mildly increased   &lt;30</p></td></tr><tr><td colspan="4"><span class="content_span">LIPID PANEL WITH REFLEX TO DIRECT LDL (14852)</span><br/>Reviewed date:[REDACTED] 11:08:30 PM<br/>Interpretation:<br/>Performing Lab:MI, Quest Diagnostics-Miami
[REDACTED][REDACTED] Julie L Friedman<br/>Notes/Report:<br/>FASTING:YES<br/>FASTING: YES</td></tr><tr><td ID="result3_attr1">CHOLESTEROL, TOTAL</td><td>131</td><td>&lt;200 mg/dL</td><td/></tr><tr><td ID="result3_attr2">HDL CHOLESTEROL</td><td>57</td><td>&gt; OR = 40 mg/dL</td><td/></tr><tr><td ID="result3_attr3">TRIGLYCERIDES</td><td>79</td><td>&lt;150 mg/dL</td><td/></tr><tr><td ID="result3_attr4">LDL-CHOLESTEROL</td><td>58</td><td/><td ID="result3_attr4_notes"><p>Desirable range &lt;100 mg/dL for primary prevention;</p><p>&lt;70 mg/dL for patients with CHD or diabetic patients</p><p>Reference range: &lt;100</p><p>estimation of LDL-C.</p><p>(http://education.QuestDiagnostics.com/faq/FAQ164)</p><p>LDL-C is now calculated using the [REDACTED]</p><p>with &gt; or = 2 CHD risk factors.</p><p>better accuracy than the Friedewald equation in the</p><p>[REDACTED] et al. JAMA. 2013;310(19): [REDACTED]-[REDACTED]</p><p>calculation, which is a validated novel method providing</p></td></tr><tr><td ID="result3_attr5">CHOL/HDLC RATIO</td><td>2.3</td><td>&lt;5.0 (calc)</td><td/></tr><tr><td ID="result3_attr6">NON HDL CHOLESTEROL</td><td>74</td><td>&lt;130 mg/dL (calc)</td><td ID="result3_attr6_notes"><p>option.</p><p>For patients with diabetes plus 1 major ASCVD risk</p><p>(LDL-C of &lt;70 mg/dL) is considered a therapeutic</p><p>factor, treating to a non-HDL-C goal of &lt;100 mg/dL</p></td></tr><tr><td colspan="4"><span class="content_span">COMPREHENSIVE METABOLIC PANEL (10231)</span><br/>Reviewed date:[REDACTED] 11:08:30 PM<br/>Interpretation:<br/>Performing Lab:MI, Quest Diagnostics-Miami
[REDACTED][REDACTED] Julie L Friedman<br/>Notes/Report:<br/>FASTING:YES<br/>FASTING: YES</td></tr><tr><td ID="result4_attr1">GLUCOSE</td><td>132</td><td>65-99 mg/dL</td><td ID="result4_attr1_notes"><p>value &gt;125 mg/dL indicates that they may have</p><p>For someone without known diabetes, a glucose</p><p>follow-up test.</p><p>           Fasting reference interval</p><p>diabetes and this should be confirmed with a</p></td></tr><tr><td ID="result4_attr2">UREA NITROGEN (BUN)</td><td>32</td><td>7-25 mg/dL</td><td/></tr><tr><td ID="result4_attr3">CREATININE</td><td>1.43</td><td>0.70-1.22 mg/dL</td><td/></tr><tr><td ID="result4_attr4">EGFR</td><td>48</td><td>&gt; OR = 60 mL/min/1.73m2</td><td/></tr><tr><td ID="result4_attr5">BUN/CREATININE RATIO</td><td>22</td><td>6-22 (calc)</td><td/></tr><tr><td ID="result4_attr6">SODIUM</td><td>140</td><td>135-146 mmol/L</td><td/></tr><tr><td ID="result4_attr7">POTASSIUM</td><td>4.9</td><td>3.5-5.3 mmol/L</td><td/></tr><tr><td ID="result4_attr8">CHLORIDE</td><td>102</td><td>98-110 mmol/L</td><td/></tr><tr><td ID="result4_attr9">CARBON DIOXIDE</td><td>28</td><td>20-32 mmol/L</td><td/></tr><tr><td ID="result4_attr10">CALCIUM</td><td>9.7</td><td>8.6-10.3 mg/dL</td><td/></tr><tr><td ID="result4_attr11">PROTEIN, TOTAL</td><td>7.5</td><td>6.1-8.1 g/dL</td><td/></tr><tr><td ID="result4_attr12">ALBUMIN</td><td>4.3</td><td>3.6-5.1 g/dL</td><td/></tr><tr><td ID="result4_attr13">GLOBULIN</td><td>3.2</td><td>1.9-3.7 g/dL (calc)</td><td/></tr><tr><td ID="result4_attr14">ALBUMIN/GLOBULIN RATIO</td><td>1.3</td><td>1.0-2.5 (calc)</td><td/></tr><tr><td ID="result4_attr15">BILIRUBIN, TOTAL</td><td>1.6</td><td>0.2-1.2 mg/dL</td><td/></tr><tr><td ID="result4_attr16">ALKALINE PHOSPHATASE</td><td>53</td><td>35-144 U/L</td><td/></tr><tr><td ID="result4_attr17">AST</td><td>28</td><td>10-35 U/L</td><td/></tr><tr><td ID="result4_attr18">ALT</td><td>39</td><td>9-46 U/L</td><td/></tr><tr><td colspan="4"><span class="content_span">CBC (INCLUDES DIFF/PLT) (6399)</span><br/>Reviewed date:[REDACTED] 11:08:30 PM<br/>Interpretation:<br/>Performing Lab:MI, Quest Diagnostics-Miami
[REDACTED][REDACTED] Julie L Friedman<br/>Notes/Report:<br/>FASTING:YES<br/>FASTING: YES</td></tr><tr><td ID="result5_attr1">WHITE BLOOD CELL COUNT</td><td>11.4</td><td>3.8-10.8 Thousand/uL</td><td/></tr><tr><td ID="result5_attr2">RED BLOOD CELL COUNT</td><td>5.31</td><td>4.20-5.80 Million/uL</td><td/></tr><tr><td ID="result5_attr3">HEMOGLOBIN</td><td>15.8</td><td>13.2-17.1 g/dL</td><td/></tr><tr><td ID="result5_attr4">HEMATOCRIT</td><td>47.6</td><td>38.5-50.0 %</td><td/></tr><tr><td ID="result5_attr5">MCV</td><td>89.6</td><td>80.0-100.0 fL</td><td/></tr><tr><td ID="result5_attr6">MCH</td><td>29.8</td><td>27.0-33.0 pg</td><td/></tr><tr><td ID="result5_attr7">MCHC</td><td>33.2</td><td>32.0-36.0 g/dL</td><td ID="result5_attr7_notes"><p>red cell parameters and the patient's clinical</p><p>value (in the range of 30 to 32 g/dL) is most likely</p><p>condition.</p><p>For adults, a slight decrease in the calculated MCHC</p><p>interpreted with caution in correlation with other</p><p>not clinically significant; however, it should be</p></td></tr><tr><td ID="result5_attr8">RDW</td><td>13.4</td><td>11.0-15.0 %</td><td/></tr><tr><td ID="result5_attr9">PLATELET COUNT</td><td>167</td><td>140-400 Thousand/uL</td><td/></tr><tr><td ID="result5_attr10">MPV</td><td>10.1</td><td>7.5-12.5 fL</td><td/></tr><tr><td ID="result5_attr11">ABSOLUTE NEUTROPHILS</td><td>8778</td><td>1500-7800 cells/uL</td><td/></tr><tr><td ID="result5_attr12">ABSOLUTE LYMPHOCYTES</td><td>1539</td><td>850-3900 cells/uL</td><td/></tr><tr><td ID="result5_attr13">ABSOLUTE MONOCYTES</td><td>1037</td><td>200-950 cells/uL</td><td/></tr><tr><td ID="result5_attr14">ABSOLUTE EOSINOPHILS</td><td>34</td><td>15-500 cells/uL</td><td/></tr><tr><td ID="result5_attr15">ABSOLUTE BASOPHILS</td><td>11</td><td>0-200 cells/uL</td><td/></tr><tr><td ID="result5_attr16">NEUTROPHILS</td><td>77</td><td/><td/></tr><tr><td ID="result5_attr17">LYMPHOCYTES</td><td>13.5</td><td/><td/></tr><tr><td ID="result5_attr18">MONOCYTES</td><td>9.1</td><td/><td/></tr><tr><td ID="result5_attr19">EOSINOPHILS</td><td>0.3</td><td/><td/></tr><tr><td ID="result5_attr20">BASOPHILS</td><td>0.1</td><td/><td/></tr><tr><td colspan="4"><span class="content_span">URINALYSIS, COMPLETE W/REFLEX TO CULTURE (3020)</span><br/>Reviewed date:[REDACTED] 11:08:30 PM<br/>Interpretation:<br/>Performing Lab:MI, Quest Diagnostics-Miami
[REDACTED][REDACTED] Julie L Friedman<br/>Notes/Report:<br/>FASTING:YES<br/>FASTING: YES<br/>FASTING:YES<br/>FASTING: YES</td></tr><tr><td ID="result6_attr1">COLOR</td><td>YELLOW</td><td>YELLOW</td><td/></tr><tr><td ID="result6_attr2">APPEARANCE</td><td>CLEAR</td><td>CLEAR</td><td/></tr><tr><td ID="result6_attr3">SPECIFIC GRAVITY</td><td>1.022</td><td>1.001-1.035</td><td/></tr><tr><td ID="result6_attr4">PH</td><td>6.0</td><td>5.0-8.0</td><td/></tr><tr><td ID="result6_attr5">GLUCOSE</td><td>NEGATIVE</td><td>NEGATIVE</td><td/></tr><tr><td ID="result6_attr6">BILIRUBIN</td><td>NEGATIVE</td><td>NEGATIVE</td><td/></tr><tr><td ID="result6_attr7">KETONES</td><td>NEGATIVE</td><td>NEGATIVE</td><td/></tr><tr><td ID="result6_attr8">OCCULT BLOOD</td><td>NEGATIVE</td><td>NEGATIVE</td><td/></tr><tr><td ID="result6_attr9">PROTEIN</td><td>1+</td><td>NEGATIVE</td><td/></tr><tr><td ID="result6_attr10">NITRITE</td><td>NEGATIVE</td><td>NEGATIVE</td><td/></tr><tr><td ID="result6_attr11">LEUKOCYTE ESTERASE</td><td>NEGATIVE</td><td>NEGATIVE</td><td/></tr><tr><td ID="result6_attr12">WBC</td><td>NONE SEEN</td><td>&lt; OR = 5 /HPF</td><td/></tr><tr><td ID="result6_attr13">RBC</td><td>NONE SEEN</td><td>&lt; OR = 2 /HPF</td><td/></tr><tr><td ID="result6_attr14">SQUAMOUS EPITHELIAL CELLS</td><td>NONE SEEN</td><td>&lt; OR = 5 /HPF</td><td/></tr><tr><td ID="result6_attr15">BACTERIA</td><td>NONE SEEN</td><td>NONE SEEN /HPF</td><td/></tr><tr><td ID="result6_attr16">HYALINE CAST</td><td>NONE SEEN</td><td>NONE SEEN /LPF</td><td/></tr><tr><td ID="result6_attr17">NOTE</td><td/><td/><td ID="result6_attr17_notes"><p>This urine was analyzed for the presence of WBC,</p><p>RBC, bacteria, casts, and other formed elements.</p><p>Only those elements seen were reported.</p></td></tr><tr><td ID="result6_attr18">REFLEXIVE URINE CULTURE</td><td/><td/><td ID="result6_attr18_notes">NO CULTURE INDICATED</td></tr><tr><td colspan="4"><span class="content_span">HEMOGLOBIN A1c (496)</span><br/>Reviewed date:[REDACTED] 11:08:31 PM<br/>Interpretation:<br/>Performing Lab:MI, Quest Diagnostics-Miami
[REDACTED][REDACTED] Julie L Friedman<br/>Notes/Report:<br/>FASTING:YES<br/>FASTING: YES</td></tr><tr><td ID="result7_attr1">HEMOGLOBIN A1c</td><td>7.1</td><td>&lt;5.7 % of total Hgb</td><td ID="result7_attr1_notes"><p>duration of diabetes, age, comorbid conditions, and</p><p>other considerations.</p><p>test.</p><p>that their diabetes is well controlled and a value</p><p>For someone with known diabetes, a value &lt;7% indicates</p><p>For someone without known diabetes, a hemoglobin A1c</p><p>diabetes and this should be confirmed with a follow-up</p><p>control. A1c targets should be individualized based on</p><p>hemoglobin A1c for diagnosis of diabetes for children.</p><p>Currently, no consensus exists regarding use of</p><p>greater than or equal to 7% indicates suboptimal</p><p>value of 6.5% or greater indicates that they may have</p></td></tr><tr><td colspan="4"><span class="content_span">CEA (978)</span><br/>Reviewed date:[REDACTED] 11:08:31 PM<br/>Interpretation:<br/>Performing Lab:MI, Quest Diagnostics-Miami
[REDACTED][REDACTED] Julie L Friedman<br/>Notes/Report:<br/>FASTING:YES<br/>FASTING: YES</td></tr><tr><td ID="result8_attr1">CEA</td><td>3.9</td><td>See Note: ng/mL</td><td ID="result8_attr1_notes"><p/><p>This test was performed using the Siemens</p><p>chemiluminescent method. Values obtained from</p><p>Non-Smoker: &lt;2.5</p><p>Reference Range:</p><p>value, should not be interpreted as absolute</p><p>evidence of the presence or absence of disease.</p><p>interchangeably. CEA levels, regardless of</p><p>different assay methods cannot be used</p><p>Smoker:     &lt;5.0</p></td></tr><tr><td colspan="4"><span class="content_span">TSH W/REFLEX TO FT4 (36127)</span><br/>Reviewed date:[REDACTED] 11:08:31 PM<br/>Interpretation:<br/>Performing Lab:MI, Quest Diagnostics-Miami
[REDACTED][REDACTED] Julie L Friedman<br/>Notes/Report:<br/>FASTING:YES<br/>FASTING: YES</td></tr><tr><td ID="result9_attr1">TSH W/REFLEX TO FT4</td><td>1.24</td><td>0.40-4.50 mIU/L</td><td/></tr><tr><td colspan="4"><span class="content_span">ALBUMIN, RANDOM URINE W/CREATININE (6517)</span><br/>Reviewed date:[REDACTED] 11:45:18 AM<br/>Interpretation:<br/>Performing Lab:MI, Quest Diagnostics-Miami
[REDACTED][REDACTED] [REDACTED]<br/>Notes/Report:<br/>FASTING: UNKNOWN</td></tr><tr><td ID="result10_attr1">CREATININE, RANDOM URINE</td><td>171</td><td>20-320 mg/dL</td><td/></tr><tr><td ID="result10_attr2">ALBUMIN, URINE</td><td>11.7</td><td>See Note: mg/dL</td><td ID="result10_attr2_notes"><p>Reference Range</p><p>Not established</p><p>Reference Range:</p></td></tr><tr><td ID="result10_attr3">ALBUMIN/CREATININE RATIO, RANDOM URINE</td><td>68</td><td>&lt;30 mg/g creat</td><td ID="result10_attr3_notes"><p>Albuminuria Category        Result (mg/g creatinine)</p><p>The ADA defines abnormalities in albumin</p><p>excretion as follows:</p><p>Severely increased           &gt; OR = 300</p><p>within a diagnostic category.</p><p>The ADA recommends that at least two of three</p><p>Moderately increased         30-299</p><p>Normal to Mildly increased   &lt;30</p><p>abnormal before considering a patient to be</p><p>specimens collected within a 3-6 month period be</p></td></tr><tr><td colspan="4"><span class="content_span">COMPREHENSIVE METABOLIC PANEL (10231)</span><br/>Reviewed date:[REDACTED] 11:45:44 AM<br/>Interpretation:<br/>Performing Lab:MI, Quest Diagnostics-Miami
[REDACTED][REDACTED] Julie L Friedman<br/>Notes/Report:<br/>FASTING: UNKNOWN</td></tr><tr><td ID="result11_attr1">GLUCOSE</td><td>132</td><td>65-99 mg/dL</td><td ID="result11_attr1_notes"><p/><p>follow-up test.</p><p>diabetes and this should be confirmed with a</p><p>           Fasting reference interval</p><p>value &gt;125 mg/dL indicates that they may have</p><p>For someone without known diabetes, a glucose</p></td></tr><tr><td ID="result11_attr2">UREA NITROGEN (BUN)</td><td>22</td><td>7-25 mg/dL</td><td/></tr><tr><td ID="result11_attr3">CREATININE</td><td>1.49</td><td>0.70-1.22 mg/dL</td><td/></tr><tr><td ID="result11_attr4">EGFR</td><td>46</td><td>&gt; OR = 60 mL/min/1.73m2</td><td/></tr><tr><td ID="result11_attr5">BUN/CREATININE RATIO</td><td>15</td><td>6-22 (calc)</td><td/></tr><tr><td ID="result11_attr6">SODIUM</td><td>139</td><td>135-146 mmol/L</td><td/></tr><tr><td ID="result11_attr7">POTASSIUM</td><td>5.1</td><td>3.5-5.3 mmol/L</td><td/></tr><tr><td ID="result11_attr8">CHLORIDE</td><td>103</td><td>98-110 mmol/L</td><td/></tr><tr><td ID="result11_attr9">CARBON DIOXIDE</td><td>31</td><td>20-32 mmol/L</td><td/></tr><tr><td ID="result11_attr10">CALCIUM</td><td>9.9</td><td>8.6-10.3 mg/dL</td><td/></tr><tr><td ID="result11_attr11">PROTEIN, TOTAL</td><td>7.1</td><td>6.1-8.1 g/dL</td><td/></tr><tr><td ID="result11_attr12">ALBUMIN</td><td>4.1</td><td>3.6-5.1 g/dL</td><td/></tr><tr><td ID="result11_attr13">GLOBULIN</td><td>3.0</td><td>1.9-3.7 g/dL (calc)</td><td/></tr><tr><td ID="result11_attr14">ALBUMIN/GLOBULIN RATIO</td><td>1.4</td><td>1.0-2.5 (calc)</td><td/></tr><tr><td ID="result11_attr15">BILIRUBIN, TOTAL</td><td>1.3</td><td>0.2-1.2 mg/dL</td><td/></tr><tr><td ID="result11_attr16">ALKALINE PHOSPHATASE</td><td>57</td><td>35-144 U/L</td><td/></tr><tr><td ID="result11_attr17">AST</td><td>22</td><td>10-35 U/L</td><td/></tr><tr><td ID="result11_attr18">ALT</td><td>26</td><td>9-46 U/L</td><td/></tr></tbody></table></div><h3><a name="id3" href="#toc">Reason For Referral</a></h3><div><table width="100%" border="1"><tbody><tr><th>Reason</th><td>NEW PT EVAL AND TX - GI - [REDACTED]</td></tr><tr><th>Diagnosis 1</th><td>HISTORY OF COLON CANCER IN ADULTHOOD (Z85.038)</td></tr><tr><th>Diagnosis 2</th><td>Elevated CEA (R97.0)</td></tr><tr><th>Referral Organization</th><td>MCM [REDACTED]</td></tr><tr><th>Referring Provider First Name</th><td>[REDACTED]</td></tr><tr><th>Referring Provider Last Name</th><td>[REDACTED]</td></tr><tr><th>Referring Provider Speciality</th><td>Physician Assistant</td></tr><tr><th>Referred Provider</th><td>[REDACTED]</td></tr><tr><th>Referred Provider Specialty</th><td>Gastroenterology</td></tr><tr><th>Referral Priority</th><td>Routine</td></tr></tbody></table><table width="100%" border="1"><tbody><tr><th>Reason</th><td>IN HOUSE ECHO</td></tr><tr><th>Diagnosis 1</th><td>Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease (I12.9)</td></tr><tr><th>Referral Organization</th><td>MCM Pompano Beach Atlantic Blvd.</td></tr><tr><th>Referring Provider First Name</th><td>[REDACTED]</td></tr><tr><th>Referring Provider Last Name</th><td>[REDACTED]</td></tr><tr><th>Referring Provider Speciality</th><td>Physician Assistant</td></tr><tr><th>Referred Provider</th><td>Med Tech Imaging, Inc</td></tr><tr><th>Referred Provider Specialty</th><td>Diagnostic Radiology</td></tr><tr><th>General Notes</th><td>[REDACTED] [REDACTED] 08:00:13 AM &gt;EMAILED</td></tr><tr><th>Referral Priority</th><td>Routine</td></tr></tbody></table><table width="100%" border="1"><tbody><tr><th>Reason</th><td>NEEDS DM EYE EXAM</td></tr><tr><th>Diagnosis 1</th><td>Encounter for examination of eyes and vision without abnormal findings (Z01.00)</td></tr><tr><th>Referral Organization</th><td>MCM Pompano Beach Atlantic Blvd.</td></tr><tr><th>Referring Provider First Name</th><td>[REDACTED]</td></tr><tr><th>Referring Provider Last Name</th><td>[REDACTED]</td></tr><tr><th>Referring Provider Speciality</th><td>Family Medicine</td></tr><tr><th>Referred Provider</th><td>[REDACTED]</td></tr><tr><th>Referred Provider Specialty</th><td>Optometrist</td></tr><tr><th>General Notes</th><td>[REDACTED] [REDACTED] 11:46:58 AM &gt;FAXED [REDACTED]</td></tr><tr><th>Referral Priority</th><td>Routine</td></tr></tbody></table></div><h3><a name="id4" href="#toc">Medications</a></h3><div><table width="100%" border="1"><thead><tr><th>Medication</th><th>SIG (Take, Route, Frequency, Duration)</th><th>Notes</th><th>Start Date</th><th>End Date</th><th>Status</th></tr></thead><tbody><tr><td ID="medication1">glipiZIDE 5 MG</td><td ID="instruction1">TAKE 1 TABLET BY MOUTH EVERY DAY 30 MINUTES BEFORE BREAKFAST FOR 90 DAYS for 90</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication2">Lisinopril 20 MG</td><td ID="instruction2">1 tablet Orally Once a day for 90 days</td><td/><td>[REDACTED]</td><td/><td>Active</td></tr><tr><td ID="medication3">Aspirin 81 81 MG</td><td ID="instruction3">1 tablet Orally Once a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication4">Tylenol Extra Strength 500 MG</td><td ID="instruction4">2 tablet Orally at bedtime</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication5">tiZANidine HCl 2 MG</td><td ID="instruction5">1 tablet as needed Orally twice daily for 15 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication6">Atorvastatin Calcium 40 MG</td><td ID="instruction6">1 tablet Orally Once a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication7">Albuterol Sulfate HFA 108 (90 Base) MCG/ACT</td><td ID="instruction7">1 puff as needed Inhalation every 4 hrs for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication8">Tamsulosin HCl 0.4 MG</td><td ID="instruction8">TAKE 1 CAPSULE BY MOUTH EVERY DAY Orally Once a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication9">Xarelto 20 MG</td><td ID="instruction9">1 tablet with food Orally Once a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication10">Breo Ellipta 100-25 MCG/ACT</td><td ID="instruction10">1 puff Inhalation Once a day for 90 days</td><td/><td/><td/><td>Active</td></tr></tbody></table></div><h3><a name="id5" href="#toc">Immunizations</a></h3><div><table width="100%" border="1"><thead><tr><th>Vaccine</th><th>Route</th><th>Administration Date</th><th>Status</th><th>Comments</th></tr></thead><tbody><tr><td ID="immunization1">FLUAD HD - Comm</td><td>IM Intramuscular</td><td>[REDACTED]</td><td>Administered</td><td/></tr><tr><td ID="immunization2">Influenza (whole)</td><td>Unknown</td><td>[REDACTED]</td><td>Administered</td><td ID="immunization2notes">  Immunization Given by from source eCW:: </td></tr><tr><td ID="immunization3">Influenza (whole)</td><td>Unknown</td><td>[REDACTED]</td><td>Administered</td><td ID="immunization3notes">  Immunization Given by from source eCW:: </td></tr><tr><td ID="immunization4">Pneumococcal conjugate PCV 13</td><td>Unknown</td><td>[REDACTED]</td><td>Administered</td><td ID="immunization4notes">  Immunization Given by from source eCW:: </td></tr></tbody></table></div><h3><a name="id6" href="#toc">Social History</a></h3><div><span class="content_span">Sex Assigned At Birth:</span><table width="100%" border="1"><thead><tr><th>Social History Observation</th><th>Description</th></tr></thead><tbody><tr><td ID="BirthSexInfo">Sex Assigned At Birth</td><td>Male</td></tr></tbody></table></div><h3><a name="id7" href="#toc">Problems</a></h3><div><table width="100%" border="1"><thead><tr><th>Problem Type</th><th>SNOMED Code</th><th>ICD Code</th><th>Onset Dates</th><th>Problem Status</th><th>W/U Status</th><th>Risk</th><th>Notes</th></tr></thead><tbody><tr><td>Problem</td><td>234467004</td><td ID="Problem1">Other thrombophilia (D68.69)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems1notes">d/t AFib; on Xarelto</td></tr><tr><td>Problem</td><td>Diabetic renal disease (127013003)</td><td ID="Problem2">Type 2 diabetes mellitus with diabetic nephropathy (E11.21)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>104931000119100</td><td ID="Problem3">Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease (I12.9)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems3notes">CKD 3A - STABLE ON BP MEDS</td></tr><tr><td>Problem</td><td>96731000119100</td><td ID="Problem4">Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease (I13.0)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems4notes">[REDACTED] tte Dyast dysfn and LVH - stable on BP med</td></tr><tr><td>Problem</td><td>441530006</td><td ID="Problem5">Chronic diastolic (congestive) heart failure (I50.32)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems5notes">stable on BP medication</td></tr><tr><td>Problem</td><td>81680005</td><td ID="Problem6">Cervicalgia (M54.2)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems6notes">s/p hospital d/c - continue Tylenol extra strength prn, advised patient to stop Ibuprofen as he is on Xarelto - will switch Methocarbamol to Tizanidine as safer in his age range</td></tr><tr><td>Problem</td><td>305058001</td><td ID="Problem7">Encounter for screening examination for mental health and behavioral disorders, unspecified (Z13.30)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems7notes">Abnormal mini-cog, score 0/5, on [REDACTED]. Abnormal mini-cog, score 23/30 on [REDACTED]</td></tr><tr><td>Problem</td><td>459311000124104</td><td ID="Problem8">Long term (current) use of oral hypoglycemic drugs (Z79.84)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems8notes">on Glipizide</td></tr><tr><td>Problem</td><td>33286000</td><td ID="Problem9">Immunodeficiency due to conditions classified elsewhere (D84.81)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems9notes">d/t COPD; on Albuterol prn--WIXELA</td></tr><tr><td>Problem</td><td>162864005</td><td ID="Problem10">Body mass index [BMI] 30.0-30.9, adult (Z68.30)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>711150003</td><td ID="Problem11">Long term current use of anticoagulant (Z79.01)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems11notes">on xarelto - due for monthly PT/INR - followed by [REDACTED]</td></tr><tr><td>Problem</td><td>Vitamin D deficiency (34713006)</td><td ID="Problem12">Mild vitamin D deficiency (E55.9)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems12notes">OTC VIt D</td></tr><tr><td>Problem</td><td>44054006</td><td ID="Problem13">Type 2 diabetes mellitus with other specified complication, without long-term current use of insulin (E11.69)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems13notes">d/t HLD; on statin</td></tr><tr><td>Problem</td><td>13645005</td><td ID="Problem14">Chronic obstructive pulmonary disease, unspecified COPD type (J44.9)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems14notes">ON 2 INHALERS</td></tr><tr><td>Problem</td><td>55822004</td><td ID="Problem15">Hyperlipidemia, unspecified hyperlipidemia type (E78.5)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems15notes">on statin</td></tr><tr><td>Problem</td><td>840306007</td><td ID="Problem16">Mild pulmonary hypertension (I27.20)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems16notes">per ECHO [REDACTED]- BP controlled</td></tr><tr><td>Problem</td><td>427679007</td><td ID="Problem17">Mild intermittent asthma without complication (J45.20)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>87522002</td><td ID="Problem18">Iron deficiency anemia, unspecified iron deficiency anemia type (D50.9)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems18notes">Rx OTC Ferrous sulfate- monitor labs</td></tr><tr><td>Problem</td><td>10692761000119107</td><td ID="Problem19">Asthma with COPD (chronic obstructive pulmonary disease) (J44.9)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems19notes">on Albuterol prn - refer Conversio program</td></tr><tr><td>Problem</td><td>445201008</td><td ID="Problem20">Elevated CEA (R97.0)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems20notes">CEA high 3.9 - Hx of colon cancer 1999 - discussed case with [REDACTED], will refer GI</td></tr><tr><td>Problem</td><td>191519005</td><td ID="Problem21">Dementia in other diseases classified elsewhere, unspecified severity, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety (F02.80)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems21notes">BASED ON MINI COG AND MINI MENTAL ON [REDACTED]--NO MEDS</td></tr><tr><td>Problem</td><td>278849000</td><td ID="Problem22">CEREBRAL ATROPHY (G31.9)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems22notes">CT BRAIN DURING ER VISIT AT IPMC ON [REDACTED] SHOWED VOLUME LOSS--NO MEDS</td></tr><tr><td>Problem</td><td>Benign enlargement of prostate (266569009)</td><td ID="Problem23">Benign enlargement of prostate (N40.0)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems23notes">on tamsulosin</td></tr><tr><td>Problem</td><td>History of malignant neoplasm of colon (429699009)</td><td ID="Problem24">HISTORY OF COLON CANCER IN ADULTHOOD (Z85.038)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems24notes">TX WITH PARTIAL COLECTOMY --1999 --- RECENT CEA ELEVATED WILL REFER GI</td></tr><tr><td>Problem</td><td>Chronic kidney disease stage 3A (disorder) (700378005)</td><td ID="Problem25">CKD Stage 3A (N18.31)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems25notes">GFR=48 03/2025--ON ACE -- CONTINUE 60OZ FLUIDS DAILY</td></tr><tr><td>Problem</td><td>128049000</td><td ID="Problem26">Cervical spondylitis (M46.92)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems26notes">CT C-SPINE DURING ER VISIT AT [REDACTED] ON [REDACTED] SHOWED SPONDYLYTIC STRAIGHTENING OF CERVICAL LORDOSIS--NO MEDS</td></tr><tr><td>Problem</td><td>Diabetic renal disease (127013003)</td><td ID="Problem27">Type 2 diabetes mellitus with diabetic chronic kidney disease (E11.22)</td><td>[REDACTED]</td><td>Active</td><td>confirmed</td><td/><td ID="problems27notes">GFR=46 ON [REDACTED]--ON ACE</td></tr><tr><td>Problem</td><td>Paroxysmal atrial fibrillation (282825002)</td><td ID="Problem28">Paroxysmal atrial fibrillation (I48.0)</td><td>[REDACTED]</td><td>Active</td><td>confirmed</td><td/><td ID="problems28notes">on Xarelto</td></tr><tr><td>Problem</td><td>History of heart valve repair with prosthesis (285701000119108)</td><td ID="Problem29">Presence of prosthetic heart valve (Z95.2)</td><td>[REDACTED]</td><td>Active</td><td>confirmed</td><td/><td ID="problems29notes">AORTIC VALVE</td></tr><tr><td>Problem</td><td>Atherosclerosis of aorta (81817003)</td><td ID="Problem30">Atherosclerosis of aorta (I70.0)</td><td>[REDACTED]</td><td>Active</td><td>confirmed</td><td/><td ID="problems30notes">2D ECHO DATED [REDACTED] SHOWS MODERATE AORTIC SCLEROSIS---ON ASA/ Statin</td></tr><tr><td>Problem</td><td>Hyperglycemia due to type 2 diabetes mellitus (368051000119109)</td><td ID="Problem31">Type 2 diabetes mellitus with hyperglycemia (E11.65)</td><td>[REDACTED]</td><td>Active</td><td>confirmed</td><td/><td ID="problems31notes">A1C=7.1 ON [REDACTED]--On Glipizide</td></tr><tr><td>Problem</td><td>Anemia in chronic kidney disease (707323002)</td><td ID="Problem32">Anemia in chronic kidney disease (D63.1)</td><td>[REDACTED]</td><td>Inactive</td><td>confirmed</td><td/><td/></tr></tbody></table></div><h3><a name="id8" href="#toc">Vital Signs</a></h3><div><table width="100%" border="1"><tbody><tr><th ID="vital1">Heart Rate</th><td>59 /min</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital2">Temperature</th><td>97.7 degrees Fahrenheit</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital3">Respiratory Rate</th><td>16 /min</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital4">Height-cm</th><td>180.34 cm</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital5">Oximetry</th><td>90 %</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital6">Blood pressure diastolic</th><td>81 mm Hg</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital7">Weight-kg</th><td>93.89 kg</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital8">Height</th><td>71 in</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital9">Blood pressure systolic</th><td>133 mm Hg</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital10">Weight</th><td>207 lbs</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital11">BMI</th><td>28.87 kg/m2</td><td>[REDACTED]</td><td/></tr></tbody></table></div><h3><a name="id9" href="#toc">Procedures</a></h3><div><table width="100%" border="1"><thead><tr><th>Procedure</th><th>Date Ordered</th><th>Date Performed</th><th>Result</th><th>Body Site</th></tr></thead><tbody><tr><td ID="procedure1">HEDIS: Blood Pressure Diastolic Less than 80</td><td>[REDACTED]</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure2">HEDIS: Blood Pressure Systolic 130-139</td><td>[REDACTED]</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure3">HEDIS: TRC MRP</td><td>[REDACTED]</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure4">HEDIS: BMI 22 - 30</td><td>[REDACTED]</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure5">HEDIS: BMI 22 - 30</td><td>[REDACTED]</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure6">HEDIS: Blood Pressure Systolic 130-139</td><td>[REDACTED]</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure7">HEDIS: Blood Pressure Diastolic Less than 80</td><td>[REDACTED]</td><td/><td>N/A</td><td/></tr></tbody></table></div><h3><a name="id10" href="#toc">Encounters</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter</th><th>Location</th><th>Date</th><th>Provider</th><th>Diagnosis</th></tr></thead><tbody><tr><td>MCM [REDACTED]</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Cervicalgia M54.2 ; Body mass index [BMI] 30.0-30.9, adult Z68.30 and Encounter for immunization Z23</td></tr><tr><td>MCM [REDACTED]</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Type 2 diabetes mellitus with other specified complication, without long-term current use of insulin E11.69 ; Hyperlipidemia, unspecified hyperlipidemia type E78.5 ; Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease I13.0 ; Chronic diastolic (congestive) heart failure I50.32 ; CKD Stage 3A N18.31 ; Asthma with COPD (chronic obstructive pulmonary disease) J44.9 ; Immunodeficiency due to conditions classified elsewhere D84.81 and Body mass index [BMI] 30.0-30.9, adult Z68.30</td></tr><tr><td>MCM [REDACTED]</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Presence of prosthetic heart valve Z95.2 ; Paroxysmal atrial fibrillation I48.0 ; Type 2 diabetes mellitus with hyperglycemia E11.65 ; Type 2 diabetes mellitus with diabetic chronic kidney disease E11.22 ; CKD Stage 3A N18.31 ; HISTORY OF COLON CANCER IN ADULTHOOD Z85.038 ; Immunodeficiency due to conditions classified elsewhere D84.81 ; Chronic obstructive pulmonary disease, unspecified COPD type J44.9 ; Cervical spondylitis M46.92 ; CEREBRAL ATROPHY G31.9 ; Dementia in other diseases classified elsewhere, unspecified severity, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety F02.80 ; Encounter for screening examination for mental health and behavioral disorders, unspecified Z13.30 ; Hyperlipidemia, unspecified hyperlipidemia type E78.5 ; Encounter for annual general medical examination with abnormal findings in adult Z00.01 and Body mass index [BMI] 29.0-29.9, adult Z68.29</td></tr><tr><td>MCM [REDACTED]</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td/></tr><tr><td>MCM [REDACTED]</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Paroxysmal atrial fibrillation I48.0 ; Encounter for annual general medical examination with abnormal findings in adult Z00.01 ; Presence of prosthetic heart valve Z95.2 ; Type 2 diabetes mellitus with hyperglycemia E11.65 ; Type 2 diabetes mellitus with diabetic chronic kidney disease E11.22 ; CKD Stage 3A N18.31 ; HISTORY OF COLON CANCER IN ADULTHOOD Z85.038 ; Immunodeficiency due to conditions classified elsewhere D84.81 ; Chronic obstructive pulmonary disease, unspecified COPD type J44.9 ; Cervical spondylitis M46.92 ; CEREBRAL ATROPHY G31.9 ; Dementia in other diseases classified elsewhere, unspecified severity, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety F02.80 ; Hyperlipidemia, unspecified hyperlipidemia type E78.5 ; Urinary frequency R35.0 and Body mass index [BMI] 29.0-29.9, adult Z68.29</td></tr><tr><td>MCM [REDACTED]</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Cervicalgia M54.2 ; HISTORY OF COLON CANCER IN ADULTHOOD Z85.038 ; Elevated CEA R97.0 ; Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease I12.9 ; CKD Stage 3A N18.31 and Body mass index [BMI] 28.0-28.9, adult Z68.28</td></tr><tr><td>MCM [REDACTED]</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Acute cough R05.1 ; Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease I13.0 ; Chronic diastolic (congestive) heart failure I50.32 ; CKD Stage 3A N18.31 ; Paroxysmal atrial fibrillation I48.0 ; Chronic obstructive pulmonary disease, unspecified COPD type J44.9 ; Other thrombophilia D68.69 ; Immunodeficiency due to conditions classified elsewhere D84.81 ; Type 2 diabetes mellitus with other specified complication, without long-term current use of insulin E11.69 ; Hyperlipidemia, unspecified hyperlipidemia type E78.5 and Body mass index [BMI] 28.0-28.9, adult Z68.28</td></tr><tr><td>MCM [REDACTED]</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td/></tr><tr><td>MCM [REDACTED]</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease I13.0 ; Chronic diastolic (congestive) heart failure I50.32 ; CKD Stage 3A N18.31 ; Paroxysmal atrial fibrillation I48.0 ; Chronic obstructive pulmonary disease, unspecified COPD type J44.9 ; Other thrombophilia D68.69 ; Immunodeficiency due to conditions classified elsewhere D84.81 ; Type 2 diabetes mellitus with other specified complication, without long-term current use of insulin E11.69 ; Hyperlipidemia, unspecified hyperlipidemia type E78.5 and Body mass index [BMI] 28.0-28.9, adult Z68.28</td></tr><tr><td>MCM [REDACTED]</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED] [REDACTED]</td><td/></tr><tr><td>MCM [REDACTED]</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED] [REDACTED]</td><td>Paroxysmal atrial fibrillation I48.0</td></tr><tr><td>MCM [REDACTED]</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED] [REDACTED]</td><td>Type 2 diabetes mellitus with diabetic chronic kidney disease E11.22</td></tr><tr><td>MCM [REDACTED]</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td/></tr><tr><td>MCM [REDACTED]</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td/></tr><tr><td>MCM [REDACTED]</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td/></tr><tr><td>[REDACTED]</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED] [REDACTED]</td><td>Hyperlipidemia, unspecified hyperlipidemia type E78.5 and Benign enlargement of prostate N40.0</td></tr><tr><td>MCM [REDACTED]</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td/></tr><tr><td>MCM [REDACTED]</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Hyperlipidemia, unspecified hyperlipidemia type E78.5 ; Chronic obstructive pulmonary disease, unspecified COPD type J44.9 ; Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease I13.0 and Paroxysmal atrial fibrillation I48.0</td></tr></tbody></table></div><h3><a name="id11" href="#toc">Medical Equipment</a></h3><div>No Information</div><h3><a name="id12" href="#toc">Assessments</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter Date</th><th>Diagnosis (ICD Code)</th><th>Assessment Notes</th><th>Treatment Notes</th><th>Treatment Clinical Notes</th><th>Section Notes</th></tr></thead><tbody><tr><td ID="ref1">[REDACTED]</td><td>Paroxysmal atrial fibrillation (ICD-10 - I48.0)</td><td/><td/><td/><td/></tr><tr><td ID="ref2">[REDACTED]</td><td>Cervicalgia (ICD-10 - M54.2)</td><td>Rx Tizandine, Tylenol, IcyHot patches, heating pad- defers imaging</td><td/><td/><td/></tr><tr><td ID="ref3">[REDACTED]</td><td>Body mass index [BMI] 30.0-30.9, adult (ICD-10 - Z68.30)</td><td/><td/><td/><td/></tr><tr><td ID="ref4">[REDACTED]</td><td>Type 2 diabetes mellitus with diabetic chronic kidney disease (ICD-10 - E11.22)</td><td/><td/><td/><td/></tr><tr><td ID="ref5">[REDACTED]</td><td>Type 2 diabetes mellitus with other specified complication, without long-term current use of insulin (ICD-10 - E11.69)</td><td>d/t HLD; on statin</td><td/><td/><td/></tr><tr><td ID="ref6">[REDACTED]</td><td>Hyperlipidemia, unspecified hyperlipidemia type (ICD-10 - E78.5)</td><td>on statin</td><td/><td/><td/></tr><tr><td ID="ref7">[REDACTED]</td><td>Presence of prosthetic heart valve (ICD-10 - Z95.2)</td><td>AORTIC VALVE</td><td>asx</td><td/><td/></tr><tr><td ID="ref8">[REDACTED]</td><td>Paroxysmal atrial fibrillation (ICD-10 - I48.0)</td><td>on Xarelto</td><td><p>Asx </p><p>on AC </p></td><td/><td/></tr><tr><td ID="ref9">[REDACTED]</td><td>Hyperlipidemia, unspecified hyperlipidemia type (ICD-10 - E78.5)</td><td>on statin</td><td/><td/><td/></tr><tr><td ID="ref10">[REDACTED]</td><td>Hyperlipidemia, unspecified hyperlipidemia type (ICD-10 - E78.5)</td><td>ON STATIN</td><td/><td/><td/></tr><tr><td ID="ref11">[REDACTED]</td><td>Paroxysmal atrial fibrillation (ICD-10 - I48.0)</td><td>on Xarelto</td><td/><td/><td/></tr><tr><td ID="ref12">[REDACTED]</td><td>Encounter for annual general medical examination with abnormal findings in adult (ICD-10 - Z00.01)</td><td/><td/><td/><td/></tr><tr><td ID="ref13">[REDACTED]</td><td>Cervicalgia (ICD-10 - M54.2)</td><td>s/p hospital d/c - continue Tylenol extra strength prn, advised patient to stop Ibuprofen as he is on Xarelto - will switch Methocarbamol to Tizanidine as safer in his age range</td><td/><td/><td/></tr><tr><td ID="ref14">[REDACTED]</td><td>HISTORY OF COLON CANCER IN ADULTHOOD (ICD-10 - Z85.038)</td><td>TX WITH PARTIAL COLECTOMY --1999 --- RECENT CEA ELEVATED WILL REFER GI</td><td/><td/><td/></tr><tr><td ID="ref15">[REDACTED]</td><td>Acute cough (ICD-10 - R05.1)</td><td>Rx Doxycycline, continue inhalers prn, Mucinex, increase fluids - advised if sxs worsen or do not improve to RTO</td><td/><td/><td/></tr><tr><td ID="ref16">[REDACTED]</td><td>Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease (ICD-10 - I13.0)</td><td>[REDACTED] tte Dyast dysfn and LVH - stable on BP med</td><td/><td/><td/></tr><tr><td ID="ref17">[REDACTED]</td><td>Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease (ICD-10 - I13.0)</td><td>[REDACTED] tte Dyast dysfn and LVH - stable on BP med</td><td/><td/><td/></tr><tr><td ID="ref18">[REDACTED]</td><td>Chronic diastolic (congestive) heart failure (ICD-10 - I50.32)</td><td>stable on BP medication</td><td/><td/><td/></tr><tr><td ID="ref19">[REDACTED]</td><td>CKD Stage 3A (ICD-10 - N18.31)</td><td>GFR=48 03/2025--ON ACE -- CONTINUE 60OZ FLUIDS DAILY</td><td/><td/><td/></tr><tr><td ID="ref20">[REDACTED]</td><td>Chronic diastolic (congestive) heart failure (ICD-10 - I50.32)</td><td>stable on BP medication</td><td/><td/><td/></tr><tr><td ID="ref21">[REDACTED]</td><td>Elevated CEA (ICD-10 - R97.0)</td><td>CEA high 3.9 - Hx of colon cancer 1999 - discussed case with [REDACTED], will refer GI</td><td/><td/><td/></tr><tr><td ID="ref22">[REDACTED]</td><td>Presence of prosthetic heart valve (ICD-10 - Z95.2)</td><td>AORTIC VALVE</td><td/><td/><td/></tr><tr><td ID="ref23">[REDACTED]</td><td>Chronic obstructive pulmonary disease, unspecified COPD type (ICD-10 - J44.9)</td><td>ON 2 INHALERS</td><td/><td/><td/></tr><tr><td ID="ref24">[REDACTED]</td><td>Benign enlargement of prostate (ICD-10 - N40.0)</td><td/><td/><td/><td/></tr><tr><td ID="ref25">[REDACTED]</td><td>Type 2 diabetes mellitus with hyperglycemia (ICD-10 - E11.65)</td><td>A1C=7.1 ON [REDACTED]--On Glipizide</td><td><p>Explained diagnosis, extensive conversation on elevated sugars and its microvascular changes that can lead to complication including but not limited to strokes, MI, CVDs, amputations, kidney failure and dialysis, blindness. It was also discussed that sugar controlled is crucial to prevent complications. We discussed proper foot and eye care and what signs to watch for.Patient understands that good management can decrease those risks significantly.</p><p>Yearly Eye and foot exam is extremely important for early diagnosis and treatment of complications.A1c goal is 6.5, fasting sugars 80-120, 2h post prandial 140 and will work on getting to goal to prevent complications</p><p>The patient is counseled to keep current medical management and a diabetic diet as well as to continue blood glucose monitoring.,</p><p>In case of Hypoglycemia aware to eat and drink sugary drinks if low sugars less than70, if no responding to ttx or profound hypoglycemia to call 911. If low sugars ok to start cutting back on insulin as needed and call for discussion</p></td><td/><td/></tr><tr><td ID="ref26">[REDACTED]</td><td>Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease (ICD-10 - I13.0)</td><td>[REDACTED] tte Dyast dysfn and LVH - stable on BP med</td><td/><td/><td/></tr><tr><td ID="ref27">[REDACTED]</td><td>Encounter for immunization (ICD-10 - Z23)</td><td/><td/><td/><td/></tr><tr><td ID="ref28">[REDACTED]</td><td>Chronic diastolic (congestive) heart failure (ICD-10 - I50.32)</td><td>stable on BP medication</td><td/><td/><td/></tr><tr><td ID="ref29">[REDACTED]</td><td>Type 2 diabetes mellitus with diabetic chronic kidney disease (ICD-10 - E11.22)</td><td>GFR=46 ON [REDACTED]--ON ACE</td><td>Advised not to take nonsteroidal anti-inflammatory drugs (NSAIDs) (e.g., ibuprofen, naproxen), with the exception of aspirin if there is  cardiovascular indications.Discussed with patient that NSAIDs have been associated with acute kidney injury in the general population and with progression of disease in those with CKD. NSAIDs may also decrease the effectiveness of certain medications, such as angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) that are often used by people with kidney disease to lower their blood pressure and protect their kidney function.BP monitoring and glucose control. Dietary sodium restriction to reduce proteinuria and to improve blood pressure control should be considered limiting intake to about 2,000 mg per day is generally accepted.
</td><td/><td/></tr><tr><td ID="ref30">[REDACTED]</td><td>Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease (ICD-10 - I13.0)</td><td/><td/><td/><td/></tr><tr><td ID="ref31">[REDACTED]</td><td>Type 2 diabetes mellitus with hyperglycemia (ICD-10 - E11.65)</td><td>A1C=7.1 ON [REDACTED]--On Glipizide</td><td/><td/><td/></tr><tr><td ID="ref32">[REDACTED]</td><td>CKD Stage 3A (ICD-10 - N18.31)</td><td>GFR=48 03/2025--ON ACE -- CONTINUE 60OZ FLUIDS DAILY</td><td/><td/><td/></tr><tr><td ID="ref33">[REDACTED]</td><td>Paroxysmal atrial fibrillation (ICD-10 - I48.0)</td><td>on Xarelto</td><td/><td/><td/></tr><tr><td ID="ref34">[REDACTED]</td><td>Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease (ICD-10 - I12.9)</td><td>CKD 3A - STABLE ON BP MEDS</td><td/><td/><td/></tr><tr><td ID="ref35">[REDACTED]</td><td>CKD Stage 3A (ICD-10 - N18.31)</td><td>GFR=48 03/2025--ON ACE -- CONTINUE 60OZ FLUIDS DAILY</td><td/><td/><td/></tr><tr><td ID="ref36">[REDACTED]</td><td>Chronic obstructive pulmonary disease, unspecified COPD type (ICD-10 - J44.9)</td><td>ON 2 INHALERS</td><td/><td/><td/></tr><tr><td ID="ref37">[REDACTED]</td><td>Paroxysmal atrial fibrillation (ICD-10 - I48.0)</td><td>on Xarelto</td><td/><td/><td/></tr><tr><td ID="ref38">[REDACTED]</td><td>Type 2 diabetes mellitus with diabetic chronic kidney disease (ICD-10 - E11.22)</td><td>GFR=46 ON [REDACTED]--ON ACE</td><td/><td/><td/></tr><tr><td ID="ref39">[REDACTED]</td><td>Paroxysmal atrial fibrillation (ICD-10 - I48.0)</td><td>on Xarelto</td><td/><td/><td/></tr><tr><td ID="ref40">[REDACTED]</td><td>CKD Stage 3A (ICD-10 - N18.31)</td><td>GFR=46 ON [REDACTED]--ON ACE</td><td>AS Above</td><td/><td/></tr><tr><td ID="ref41">[REDACTED]</td><td>CKD Stage 3A (ICD-10 - N18.31)</td><td>GFR 47 at time of ED visit on 10/2021 - BP control , Glucose control - Labs ordered</td><td/><td/><td/></tr><tr><td ID="ref42">[REDACTED]</td><td>Asthma with COPD (chronic obstructive pulmonary disease) (ICD-10 - J44.9)</td><td>on Albuterol prn - refer Conversio program</td><td/><td/><td/></tr><tr><td ID="ref43">[REDACTED]</td><td>HISTORY OF COLON CANCER IN ADULTHOOD (ICD-10 - Z85.038)</td><td>TX WITH PARTIAL COLECTOMY --1999</td><td/><td/><td/></tr><tr><td ID="ref44">[REDACTED]</td><td>CKD Stage 3A (ICD-10 - N18.31)</td><td>GFR=46 ON [REDACTED]--ON ACE</td><td/><td/><td/></tr><tr><td ID="ref45">[REDACTED]</td><td>Body mass index [BMI] 28.0-28.9, adult (ICD-10 - Z68.28)</td><td/><td/><td/><td/></tr><tr><td ID="ref46">[REDACTED]</td><td>Chronic obstructive pulmonary disease, unspecified COPD type (ICD-10 - J44.9)</td><td>ON 2 INHALERS</td><td/><td/><td/></tr><tr><td ID="ref47">[REDACTED]</td><td>Other thrombophilia (ICD-10 - D68.69)</td><td>d/t AFib; on Xarelto</td><td/><td/><td/></tr><tr><td ID="ref48">[REDACTED]</td><td>Immunodeficiency due to conditions classified elsewhere (ICD-10 - D84.81)</td><td>d/t COPD; on Albuterol prn--WIXELA</td><td/><td/><td/></tr><tr><td ID="ref49">[REDACTED]</td><td>Other thrombophilia (ICD-10 - D68.69)</td><td>d/t AFib; on Xarelto</td><td/><td/><td/></tr><tr><td ID="ref50">[REDACTED]</td><td>HISTORY OF COLON CANCER IN ADULTHOOD (ICD-10 - Z85.038)</td><td>TX WITH PARTIAL COLECTOMY --1999</td><td/><td/><td/></tr><tr><td ID="ref51">[REDACTED]</td><td>Immunodeficiency due to conditions classified elsewhere (ICD-10 - D84.81)</td><td>d/t COPD; on Albuterol prn--WIXELA</td><td/><td/><td/></tr><tr><td ID="ref52">[REDACTED]</td><td>Immunodeficiency due to conditions classified elsewhere (ICD-10 - D84.81)</td><td>d/t COPD; on Albuterol prn</td><td/><td/><td/></tr><tr><td ID="ref53">[REDACTED]</td><td>Body mass index [BMI] 30.0-30.9, adult (ICD-10 - Z68.30)</td><td/><td/><td/><td/></tr><tr><td ID="ref54">[REDACTED]</td><td>Chronic obstructive pulmonary disease, unspecified COPD type (ICD-10 - J44.9)</td><td>ON 2 INHALERS</td><td/><td/><td/></tr><tr><td ID="ref55">[REDACTED]</td><td>Immunodeficiency due to conditions classified elsewhere (ICD-10 - D84.81)</td><td>d/t COPD; on Albuterol prn--WIXELA</td><td/><td/><td/></tr><tr><td ID="ref56">[REDACTED]</td><td>Immunodeficiency due to conditions classified elsewhere (ICD-10 - D84.81)</td><td>d/t COPD; on Albuterol prn--WIXELA</td><td/><td/><td/></tr><tr><td ID="ref57">[REDACTED]</td><td>Type 2 diabetes mellitus with other specified complication, without long-term current use of insulin (ICD-10 - E11.69)</td><td>d/t HLD; on statin</td><td/><td/><td/></tr><tr><td ID="ref58">[REDACTED]</td><td>Hyperlipidemia, unspecified hyperlipidemia type (ICD-10 - E78.5)</td><td>on statin</td><td/><td/><td/></tr><tr><td ID="ref59">[REDACTED]</td><td>Type 2 diabetes mellitus with other specified complication, without long-term current use of insulin (ICD-10 - E11.69)</td><td>d/t HLD; on statin</td><td/><td/><td/></tr><tr><td ID="ref60">[REDACTED]</td><td>Chronic obstructive pulmonary disease, unspecified COPD type (ICD-10 - J44.9)</td><td>ON 2 INHALERS</td><td/><td/><td/></tr><tr><td ID="ref61">[REDACTED]</td><td>Cervical spondylitis (ICD-10 - M46.92)</td><td>CT C-SPINE DURING ER VISIT AT IPMC ON [REDACTED] SHOWED SPONDYLYTIC STRAIGHTENING OF CERVICAL LORDOSIS--NO MEDS</td><td/><td/><td/></tr><tr><td ID="ref62">[REDACTED]</td><td>CEREBRAL ATROPHY (ICD-10 - G31.9)</td><td>CT BRAIN DURING ER VISIT AT IPMC ON [REDACTED] SHOWED VOLUME LOSS--NO MEDS</td><td/><td/><td/></tr><tr><td ID="ref63">[REDACTED]</td><td>Cervical spondylitis (ICD-10 - M46.92)</td><td>CT C-SPINE DURING ER VISIT AT IPMC ON [REDACTED] SHOWED SPONDYLYTIC STRAIGHTENING OF CERVICAL LORDOSIS--NO MEDS</td><td/><td/><td/></tr><tr><td ID="ref64">[REDACTED]</td><td>Hyperlipidemia, unspecified hyperlipidemia type (ICD-10 - E78.5)</td><td>on statin</td><td/><td/><td/></tr><tr><td ID="ref65">[REDACTED]</td><td>Body mass index [BMI] 28.0-28.9, adult (ICD-10 - Z68.28)</td><td/><td/><td/><td/></tr><tr><td ID="ref66">[REDACTED]</td><td>Body mass index [BMI] 28.0-28.9, adult (ICD-10 - Z68.28)</td><td/><td/><td/><td/></tr><tr><td ID="ref67">[REDACTED]</td><td>CEREBRAL ATROPHY (ICD-10 - G31.9)</td><td>CT BRAIN DURING ER VISIT AT IPMC ON [REDACTED] SHOWED VOLUME LOSS--NO MEDS</td><td/><td/><td/></tr><tr><td ID="ref68">[REDACTED]</td><td>Dementia in other diseases classified elsewhere, unspecified severity, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety (ICD-10 - F02.80)</td><td>BASED ON MINI COG AND MINI MENTAL ON [REDACTED]--NO MEDS</td><td/><td/><td/></tr><tr><td ID="ref69">[REDACTED]</td><td>Encounter for screening examination for mental health and behavioral disorders, unspecified (ICD-10 - Z13.30)</td><td>Abnormal mini-cog, score 0/5, on [REDACTED]. Abnormal mini-cog, score 23/30 on [REDACTED]</td><td/><td/><td/></tr><tr><td ID="ref70">[REDACTED]</td><td>Dementia in other diseases classified elsewhere, unspecified severity, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety (ICD-10 - F02.80)</td><td>BASED ON MINI COG AND MINI MENTAL ON [REDACTED]--NO MEDS</td><td/><td/><td/></tr><tr><td ID="ref71">[REDACTED]</td><td>Hyperlipidemia, unspecified hyperlipidemia type (ICD-10 - E78.5)</td><td>ON STATIN</td><td/><td/><td/></tr><tr><td ID="ref72">[REDACTED]</td><td>Hyperlipidemia, unspecified hyperlipidemia type (ICD-10 - E78.5)</td><td>ON STATIN</td><td/><td/><td/></tr><tr><td ID="ref73">[REDACTED]</td><td>Encounter for annual general medical examination with abnormal findings in adult (ICD-10 - Z00.01)</td><td/><td/><td/><td/></tr><tr><td ID="ref74">[REDACTED]</td><td>Urinary frequency (ICD-10 - R35.0)</td><td>for a few months - no other urinary Sx - check UA in office [REDACTED]</td><td/><td/><td/></tr><tr><td ID="ref75">[REDACTED]</td><td>Body mass index [BMI] 29.0-29.9, adult (ICD-10 - Z68.29)</td><td/><td/><td/><td/></tr><tr><td ID="ref76">[REDACTED]</td><td>Body mass index [BMI] 29.0-29.9, adult (ICD-10 - Z68.29)</td><td/><td/><td/><td/></tr><tr><td ID="ref77">[REDACTED]</td><td>Other</td><td/><td><p>Controlled</p><p>MILD INTERMITGENT ASTHM,A AS DOCUMENTED BY PULMONARY note</p></td><td/><td/></tr></tbody></table></div><h3><a name="id13" href="#toc">Plan Of Treatment</a></h3><div><span class="content_span">Pending Test</span><table width="100%" border="1"><thead><tr><th>Test Name</th><th>Order Date</th></tr></thead><tbody><tr><td ID="pendingTest1">Microalb/Creat Ratio, Randm Ur</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest2">ALBUMIN, RANDOM URINE W/CREATININE (6517)</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest3">COMPREHENSIVE METABOLIC PANEL (10231)</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest4">URINALYSIS REFLEX (7909)</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest5">HEMOGLOBIN A1c (496)</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest6">HEDIS: Blood Pressure Diastolic Less than 80</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest7">HEDIS: Blood Pressure Diastolic Less than 80</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest8">HEDIS: Blood Pressure Diastolic Less than 80</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest9">HEDIS: Blood Pressure Systolic &lt; 130</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest10">HEDIS: Blood Pressure Systolic 130-139</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest11">HEDIS: Blood Pressure Systolic 130-139</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest12">HEDIS: TRC MRP</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest13">HEDIS: BMI 22 - 30</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest14">HEDIS: BMI 22 - 30</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest15">HEDIS: BMI 22 - 30</td><td>[REDACTED]</td></tr></tbody></table><span class="content_span">Future Test</span><table width="100%" border="1"><thead><tr><th>Test Name</th><th>Order Date</th></tr></thead><tbody><tr><td ID="futureTest1">Microalb/Creat Ratio, Randm Ur</td><td>[REDACTED]</td></tr><tr><td ID="futureTest2">COMPREHENSIVE METABOLIC PANEL (10231)</td><td>[REDACTED]</td></tr><tr><td ID="futureTest3">LIPID PANEL WITH REFLEX TO DIRECT LDL (14852)</td><td>[REDACTED]</td></tr><tr><td ID="futureTest4">COMPREHENSIVE METABOLIC PANEL (10231)</td><td>[REDACTED]</td></tr><tr><td ID="futureTest5">URINALYSIS, COMPLETE W/REFLEX TO CULTURE (3020)</td><td>[REDACTED]</td></tr><tr><td ID="futureTest6">CEA (978)</td><td>[REDACTED]</td></tr><tr><td ID="futureTest7">Echocardiogram</td><td>[REDACTED]</td></tr></tbody></table><span class="content_span">Next Appt</span><table width="100%" border="1"><thead><tr><th>Details</th></tr></thead><tbody><tr><td ID="futureAppt1">Provider Name:[REDACTED], [REDACTED] 01:40:00 PM, [REDACTED][REDACTED], [REDACTED]</td></tr><tr><td ID="futureAppt2">Provider Name:[REDACTED], [REDACTED] 01:40:00 PM, [REDACTED][REDACTED], [REDACTED]</td></tr><tr><td ID="futureAppt3">Provider Name:[REDACTED], [REDACTED] 08:45:00 AM, [REDACTED][REDACTED], [REDACTED]</td></tr><tr><td ID="futureAppt4">Provider Name:[REDACTED], [REDACTED] 02:40:00 PM, [REDACTED][REDACTED], [REDACTED]</td></tr></tbody></table></div><h3><a name="id14" href="#toc">Goals Section</a></h3><div>No Information</div><h3><a name="id15" href="#toc">Health Concerns</a></h3><div>No Information</div><h3><a name="id16" href="#toc">Insurance Providers</a></h3><div><table width="100%" border="1"><thead><tr><th>Payer Name</th><th>Payer Address</th><th>Payer Phone</th><th>Subscriber Number</th><th>Group Number</th><th>Insured Name</th><th>Patient Relationship to Insured</th><th>Coverage Start Date</th><th>Coverage End Date</th></tr></thead><tbody><tr><td>Humana Gold Plus South FL Cap</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>H57433657</td><td>Y0659001</td><td>[REDACTED]</td><td>Self - patient is the insured</td><td>[REDACTED]</td><td>[REDACTED]</td></tr><tr><td>MEDICARE [REDACTED]</td><td>PO BOX [REDACTED]</td><td>[REDACTED]</td><td>9HV2YG6EN85</td><td/><td>[REDACTED]</td><td>Self - patient is the insured</td><td/><td/></tr></tbody></table></div><h3><a name="id17" href="#toc">Medical (General) History</a></h3><div><span class="content_span">Medical History</span><table width="100%" border="1"><thead><tr><th>History</th><th>ICD Code</th></tr></thead><tbody><tr><td>CKD3</td><td/></tr><tr><td>HTN</td><td/></tr><tr><td>HLD</td><td/></tr><tr><td>T2DM</td><td/></tr><tr><td>GERD</td><td/></tr><tr><td>COLON CANCER</td><td/></tr><tr><td>Aortic stenosis s/p replacement</td><td/></tr></tbody></table><span class="content_span">Surgical History</span><table width="100%" border="1"><thead><tr><th>Surgery</th><th>Date(Month/Year)</th></tr></thead><tbody><tr><td>Cardiac Cath</td><td/></tr><tr><td>Aortic valve replacement</td><td/></tr><tr><td>Cholecystectomy</td><td/></tr><tr><td>Partial colectomy</td><td>1999</td></tr></tbody></table><span class="content_span">Hospitalization History</span><table width="100%" border="1"><thead><tr><th>Reason</th><th>Date(Month/Year)</th></tr></thead><tbody><tr><td>Motor Vehicle Accident- NBH</td><td>04/2024</td></tr></tbody></table></div><br/><br/>
</body></html>